Polymer-Stabilized Antioxidant Crystals for Extended Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing hydrophilic antioxidants for cell culture media face challenges such as rapid metabolism, low bioactivity, and variability in efficacy due to short release profiles and antioxidant stress.
Innovation Solution
A process involving the stabilization of hydrophilic antioxidants with polymers, followed by crystallization from droplets undergoing cyclic thermal treatment, results in crystalline antioxidants with extended and uniform release profiles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydrophilic antioxidants are added to cell culture media, then ROS scavenging and prevention of senescence spreading is achieved, but the antioxidants are rapidly metabolized within 6 hours resulting in short duration of action
Solution Approach 1:
The antioxidant is pre-crystallized within polymer-stabilized microdroplets before being introduced to the cell culture media. This preliminary crystallization action creates a stable reservoir that releases the antioxidant gradually, preventing rapid metabolism and extending the duration of action while maintaining reliable ROS scavenging efficacy.
2Manufacturing precision
If conventional crystallization methods are used, then antioxidant crystals are produced, but the crystals exhibit broad size distribution leading to variable release profiles and inconsistent bioactivity
Solution Approach 1:
The crystallization process is segmented into discrete microdroplets rather than using bulk solution crystallization. Each microdroplet acts as an independent reaction chamber, ensuring uniform nucleation and crystal growth conditions. This segmentation produces crystals with narrow size distribution and consistent release profiles while the microdroplet approach simplifies the overall process control compared to conventional multi-step crystallization methods.
Solution Approach 2:
The invention changes the physical parameters of the crystallization environment by confining the process to microdroplets with controlled volume and surface-to-volume ratio. This parameter change enables uniform supersaturation and crystal growth conditions, producing consistent crystal sizes and release profiles without requiring complex process equipment.
3Duration of action of moving object
If high concentrations of antioxidants are used to extend release profile, then duration of action is improved, but antioxidant stress and harmful effects increase
Solution Approach 1:
The crystalline antioxidant structure provides periodic release of the antioxidant at controlled rates rather than all-at-once delivery. This periodic action maintains therapeutic concentrations over extended periods while avoiding the harmful effects associated with high peak concentrations, thus extending duration of action without inducing antioxidant stress.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting crystalline antioxidants, known as microcrystal assembly for senescence control (MASC), effectively minimize reactive oxygen species (ROS)-triggered senescence, maintain healthy mesenchymal stem cell (MSC) phenotype, and improve therapeutic efficacy of MSC secretome.
Implementation Method 1
polymer-induced nucleation of the antioxidant occurs in the liquid droplets
Implementation Method 2
antioxidant crystal growth occurs at the lower temperature
Implementation Method 3
crystal dissolution occurs at the upper temperature
Data Source
AI summary
In one embodiment, the invention relates to a process for producing a crystalline antioxidant comprising: (1) providing an aqueous solution comprising a hydrophilic antioxidant; and a polymer selected from hyaluronate-dopamine, alginate-dopamine, chitosan-dopamine, poly(ethylene glycol) dopamine and their derivatives, or mixtures thereof; (2) forming a liquid droplet of the aqueous solution, the droplet having a diameter, wherein polymer-induced nucleation of the antioxidant occurs in the liquid droplets; (3) crystallizing the crystalline antioxidant by performing at least one of: (a) subjecting the liquid droplet to thermal cycling between a lower temperature and a higher temperature, wherein antioxidant crystal growth occurs at the lower temperature and crystal dissolution occurs at the upper temperature; and maintaining the thermal cycling until the droplet contains one or two antioxidant crystals, and (b) subjecting the liquid droplet to shear deformation using a shear-induced mixing-on-a-chip device, wherein a probability of nucleation and crystallization of each droplet is increased.